" Food is a side business for Cellectis, which focuses on pharmaceuticals. After some collaborations with big companies like Monsanto and DuPont Pioneer, Cellectis started Calyxt, to explore opportunities for using gene editing for foods. Dr. Choulika said he considered G. M. O.s safe, but that the   techniques like those used by Calyxt would be more acceptable to consumers. 